Precision Optics Corporation, Inc.
NASDAQ:POCIMedical - Instruments & Supplies
+$0.14 today
- Market cap
- $53.44M
- Beta
- 0.32
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.63
Volume 0.03M
Average 0.05M
POCI Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Precision Optics Corporation, Inc.NASDAQ: POCI
Financing Cash Flow · Q3 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q3 FY2026 financing cash flow of $10.47M rose 143.7% year over year, ahead of the +74.9% change in trailing-twelve-month financing cash flow. Over 3 fiscal years it compounded at +68.0% a year.
Context
- Financing cash flow amounted to 27.0% of revenue in FY2025, up 24.6 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +143.7% holds above the trailing-twelve-month pace of +74.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 5.15M USD
- Year-over-year change
- +1028.4%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 5.15M | +1028.4% |
| FY2024 | 2024-06-30 | 456.32K | -81.4% |
| FY2023 | 2023-06-30 | 2.45M | +126.1% |
| FY2022 | 2022-06-30 | 1.09M | +3654.4% |
| FY2021 | 2021-06-30 | (30.53K) | — |
Financing Cash Flow vs competitors
How POCI compares with its peers on the latest reported figures
- POCI's LTM Mar 2026 financing cash flow of $10.03M is the 2nd largest of the 3 companies compared; the peer median is $8.43M.
- Its year-over-year change of +74.9% is the 2nd highest of 3, against a peer median of +1695.6%.
- Financing cash flow amounts to 34.7% of revenue for POCI, versus a peer median of 163.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.46M | -26.2% | +211.8% | 27.8% | |
| LTM Mar 2026 | $10.03M | +74.9% | +68.0% | 34.7% | |
| LTM Apr 2026 | $5.4M | +3417.5% | +223.2% | 299.7% | |
| Peer median (excluding POCI) | $8.43M | +1695.6% | +217.5% | 163.8% | |
Competitors are the stored peer set for POCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | (102.84K) | (928.42K) | (144.61K) | (2.95M) | (5.78M) |
| Depreciation & Amortization | 146.8K | 190.22K | 210.74K | 212.38K | 212.44K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 733.93K | 915.49K | 919.03K | 959.78K | 1.46M |
| Change in Working Capital | 74.69K | (423.6K) | (364.44K) | (921.31K) | 513.43K |
| Accounts Receivables | (400.25K) | (108.14K) | (1.24M) | 361.92K | (791.24K) |
| Inventory | 311.85K | (680.74K) | 245.93K | (91.88K) | (694.01K) |
| Accounts Payables | 139.14K | 819.28K | 193.09K | (1.03M) | 1.51M |
| Other Working Capital | 23.94K | (454K) | 440.08K | (156.39K) | 486.9K |
| Other Non-Cash Items | (806.03K) | (687.07K) | (701.81K) | 17.5K | 46.57K |
| Operating Cash Flow | 46.55K | (933.37K) | (81.09K) | (2.68M) | (3.55M) |
| Capital Expenditures | (122.4K) | (152.74K) | (52.5K) | (293.88K) | (227.21K) |
| Acquisitions (Net) | (166.67K) | (255.06K) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (21.45K) | (6.26K) |
| Investing Cash Flow | (289.06K) | (407.8K) | (52.5K) | (293.88K) | (233.47K) |
| Debt Repayment | (58.8K) | (285.35K) | 341.95K | 443.53K | (1.32M) |
| Common Stock Issued | 28.27K | 1.5M | 2.29M | 12.79K | 6.36M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (129.38K) | (176.55K) | 12.79K | 111.7K |
| Financing Cash Flow | (30.53K) | 1.09M | 2.45M | 456.32K | 5.15M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (273.05K) | (255.9K) | 2.32M | (2.52M) | 1.37M |
| Free Cash Flow | (75.85K) | (1.09M) | (133.59K) | (2.98M) | (3.77M) |
Precision Optics Corporation, Inc.
NASDAQ:POCI
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.